Pharmaceutical composition and method for regenerating myofibers in the treatment of muscle injuries
    1.
    发明授权
    Pharmaceutical composition and method for regenerating myofibers in the treatment of muscle injuries 有权
    用于再生肌纤维治疗肌肉损伤的药物组合物和方法

    公开(公告)号:US09155744B2

    公开(公告)日:2015-10-13

    申请号:US11722915

    申请日:2006-10-27

    摘要: A pharmaceutical composition and method for regenerating cardiomyocytes in treating or repairing heart muscle damages or injuries caused by an ischemic disease. The pharmaceutical composition contains an active ingredient compound with a backbone structure of Formula (I). The active ingredient compound is capable of (a) increasing viability of myogenic precursor cells to enable said precursor cells to survive through an absolute ischemic period; (b) reconstituting a damaged blood supply network in said heart region where said injured muscle is located; and (c) enhancing cardiomyogenic differentiation efficiency of said precursor cells down cardiac linage, said steps being performed simultaneously or in any particular order.

    摘要翻译: 用于再生心肌细胞治疗或修复由缺血性疾病引起的心肌损伤或损伤的药物组合物和方法。 药物组合物含有具有式(I)的骨架结构的活性成分化合物。 活性成分化合物能够(a)增加肌原性前体细胞的活力,使所述前体细胞能够通过绝对缺血期生存; (b)在所述受伤的肌肉位于的所述心脏区域中重建损伤的血液供应网络; 和(c)提高所述前体细胞向下心肌的心肌分化效率,所述步骤同时进行或以任何特定的顺序进行。

    AGENT AND METHOD FOR ELIMINATING MALIGNANCE OF CANCER CELLS WITHOUT HARMFUL EFFECT TO NORMAL CELLS
    2.
    发明申请
    AGENT AND METHOD FOR ELIMINATING MALIGNANCE OF CANCER CELLS WITHOUT HARMFUL EFFECT TO NORMAL CELLS 审中-公开
    用于消除癌细胞恶性病变的代理和方法,对正常细胞没有有害的作用

    公开(公告)号:US20090022827A1

    公开(公告)日:2009-01-22

    申请号:US12176441

    申请日:2008-07-21

    申请人: Ming Li Lei Cheng

    发明人: Ming Li Lei Cheng

    IPC分类号: A61K36/73 A61P35/04

    CPC分类号: A61K36/73

    摘要: A pharmaceutical composition including an extract from Geum japonicum and a method of treating cancer using the extract. In vitro and in vivo experimental data demonstrated that the extract can induce selectively apoptosis of cancer cells and kill the cancer cells without affect normal cells.

    摘要翻译: 一种药用组合物,其特征在于,包括天麻提取物和使用所述提取物治疗癌症的方法。 体外和体内实验数据表明,提取物可以诱导癌细胞的选择性凋亡,并杀死癌细胞而不影响正常细胞。

    PHARMACEUTICAL COMPOSITION AND METHOD FOR REGENERATING MYOFIBERS IN THE TREATMENT OF MUSCLE INJURIES
    3.
    发明申请
    PHARMACEUTICAL COMPOSITION AND METHOD FOR REGENERATING MYOFIBERS IN THE TREATMENT OF MUSCLE INJURIES 有权
    药物组合物和方法用于在治疗肌肉损伤时再生肌孕酮

    公开(公告)号:US20090028959A1

    公开(公告)日:2009-01-29

    申请号:US11722915

    申请日:2006-10-27

    摘要: A pharmaceutical composition and method for regenerating cardiomyocytes in treating or repairing heart muscle damages or injuries caused by an ischemic disease. The pharmaceutical composition contains an active ingredient compound with a backbone structure of Formula (I). The active ingredient compound is capable of (a) increasing viability of myogenic precursor cells to enable said precursor cells to survive through an absolute ischemic period; (b) reconstituting a damaged blood supply network in said heart region where said injured muscle is located; and (c) enhancing cardiomyogenic differentiation efficiency of said precursor cells down cardiac linage, said steps being performed simultaneously or in any particular order.

    摘要翻译: 用于再生心肌细胞治疗或修复由缺血性疾病引起的心肌损伤或损伤的药物组合物和方法。 药物组合物含有具有式(I)的骨架结构的活性成分化合物。 活性成分化合物能够(a)增加肌原性前体细胞的活力,使所述前体细胞能够通过绝对缺血期生存; (b)在所述受伤的肌肉位于的所述心脏区域中重建损伤的血液供应网络; 和(c)提高所述前体细胞向下心肌的心肌分化效率,所述步骤同时进行或以任何特定的顺序进行。

    Pharmaceutical Composition and Method for Neoangiogenesis/Revascularization Useful in Treating Ischemic Heart Disease
    4.
    发明申请
    Pharmaceutical Composition and Method for Neoangiogenesis/Revascularization Useful in Treating Ischemic Heart Disease 审中-公开
    用于治疗缺血性心脏病的新血管生成/血运重建的药物组合物和方法

    公开(公告)号:US20120252744A1

    公开(公告)日:2012-10-04

    申请号:US13517600

    申请日:2012-06-14

    IPC分类号: A61K31/7034 A61P9/10

    摘要: A pharmaceutical composition and a method of treating ischemic heart diseases by growing new blood vessels that supply oxygen and nutrients to infarcted heart tissues throughout the entire infarct zone and for preventing cardiomyocyte apoptosis in ischemic events. The pharmaceutical composition contains an active ingredient compound with a backbone structure of formula (I).

    摘要翻译: 一种药物组合物和通过生长新的血管来治疗缺血性心脏病的方法,所述新血管向整个梗塞区域的梗死心脏组织供氧和营养,并用于预防缺血事件中的心肌细胞凋亡。 药物组合物含有具有式(I)的骨架结构的活性成分化合物。

    COMPOSITIONS AND METHODS FOR INCREASING LIFESPAN AND HEALTH SPAN
    5.
    发明申请
    COMPOSITIONS AND METHODS FOR INCREASING LIFESPAN AND HEALTH SPAN 有权
    组合物和增加生活和健康的范围的方法

    公开(公告)号:US20120177759A1

    公开(公告)日:2012-07-12

    申请号:US13377501

    申请日:2010-06-11

    申请人: Ming Li Lei Cheng

    发明人: Ming Li Lei Cheng

    摘要: Disclosed herein are compounds, extracts, and active fractions of the plant Geum japonicum and methods for increasing longevity and survival potency or for preventing or treating various medical conditions, including diabetes, inflammation, wound healing, bed sores, and ocular disorders. The compounds provided herein can be formulated into pharmaceutical compositions and medicaments that are useful in the disclosed methods. Also provided are the use of the compounds and extracts in preparing pharmaceutical formulations and medicaments

    摘要翻译: 本文公开了植物天麻的化合物,提取物和活性级分以及用于增加寿命和存活效力或用于预防或治疗各种医学病症(包括糖尿病,炎症,伤口愈合,褥疮和眼部疾病)的方法。 本文提供的化合物可以配制成在所公开的方法中有用的药物组合物和药物。 还提供了化合物和提取物在制备药物制剂和药物中的用途

    Method and device for encoding and decoding parameter sets at slice level

    公开(公告)号:US10298946B2

    公开(公告)日:2019-05-21

    申请号:US14355785

    申请日:2012-07-24

    申请人: Ming Li Ping Wu

    发明人: Ming Li Ping Wu

    摘要: Provided is a method for encoding parameter sets at slice level. The method includes: when there are one or more parameter sets, in which the coding tool parameters are identical to the coding tool parameters of a part of coding tools used for the current slice, in the existing parameter sets, encoding the identifiers of parameter sets into bit-stream of the current slice, wherein a parameter set contains common information of the coding tools used in the process of encoding/decoding slice(s). Correspondingly, also provided is a method for decoding parameter sets at slice level and a device for encoding and decoding parameter sets at slice level, which can make full use of the encoded parameter set information when the slice header refers to a plurality of parameter sets, implement flexible configuration of the coding tools used in the process of encoding/decoding slice(s) and reduce information redundancy.